What is INSM's current stock price?

As of now, INSM is trading at $194.22, with a daily change of +16.33%.

What are the risks associated with INSM stock?

INSM Key risk is its Moderate Risk Level, .

What is INSM next earnings date?

INSM next earnings report is scheduled for Oct 30, 2025.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

INSM Stock Analysis & IQ Rating | Insmed

INSM

Insmed

$194.22

+$27.27 | +16.33%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 194.7

MKT CAP

$ 41.05B

52W Low

$ 60.4

VOL

$ 6.73M

P/E Ratio

N/A

AVG VOL

$ 2.04M

RSI

82.29

TREND

Uptrend

alert Latest Updates

BullPower 02:44 PM

delivered an impressive 16.33% surge today, capturing traders attention with trading volume reaching 329% of its 30-day average at 6.7 million shares. This explosive move in Insmed came after the biotech company reported...

INSM Stock IQ

Login to see Insmed (INSM) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

INSM Target Price

Login to display

Strengths

INSM Rewards

Upgraded on attractively valued

INSM Rewards

Earnings are forecast to grow

INSM Rewards

Investors confidence is positive

Chart

$152.8 (+27.11%)

$111.26 (+74.56%)

$70.65 (+174.90%)

$70.14 (+176.90%)

1year

6month

3month

1month

INSM Risk Level

INSM has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

LOW

HIGH

INSM Analysts Opinion

INSM overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

INSM Analysts Opinion

INSM Analysts opinion is negative but has improved from the past 3 months

INSM Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

69%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

40%

100%

INSM Street Opinion

INSM Street view is bullish and have negative views on the near-term outlook

INSM Performance Sentiment

Sentiments overview associated with INSM events and the stock performance.

69%

25%

Positive

Negative

11 out of 16
events present

4 out of 16
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$159.88

Resistance
Price

$137.03

Current Price Range

$167.91

Show methods +

INSM Earnings

The TTM reflects 12-month period, providing review of INSM financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

398

364

305

+14.23%

Cost of Revenue

97

86

66

+21.23%

Gross Profit

301

278

240

+11.99%

Operating Exp

1,229

1,065

921

+15.52%

Operating Inc

-928

-787

-681

-

Net Interest Inc

-85

-82

-

Interest Exp

79

80

76

+1.95%

Interest Inc

1

2

-29.29%

Other Inc Exp

-17

-39

16

-

EPS Growth

-5.67

-5.57

-5.34

-

INSM Financial Health

The company financial health has shown minor improvement, but significant issues remain

Financial Score

3.17

Next Earnings Date: Oct 30, 2025

Linked to INSM

IQ

Close Price

Change

SNY

4.16

50.94

+0.51%

XOMA

4.00

33.22

-0.37%

REGN

4.17

654.04

+0.17%

MRK

4.08

86.28

-0.35%

MLTX

2.05

9.81

+2.08%

INSM Latest Analysis +

Insmed GAAP EPS of -$1.75 misses by $0.42 revenue of $142M beats by $26.51M.

Today

$194.22 | +16.33%

Earnings

Insmed Catapults While IBD 50s Argenx Creeps Higher On ish Reports. Insmed stock surged early Thursday as Argenx stock rose more moderately. The top-notch biotech companies beat third-quarter calls.The post Insmed Catapults While IBD 50'.s Argenx Creeps Higher On ish Reports appeared first on Investor'.s Business Daily.

Today

$194.22 | +16.33%

Momentum

Potential

Insmed (INSM) Reports Q3 Loss Beats Revenue Estimates. Insmed (INSM) delivered earnings and revenue surprises of -32.58% and 24.16% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Today

$194.22 | +16.33%

Earnings

Insmed (INSM) Price Target Increased by 13.59% to 178.15. The average one-year price target for Insmed (NasdaqGS:INSM) has been revised to $178.15 / share. This is an increase of 13.59% from the prior estimate of $156.83 dated September 27 2025. The price target is an average of many targets provided by analysts. Th

Today

$194.22 | +16.33%

Potential

Hidradenitis Suppurativa Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 24 Companies and 26 Therapies | DelveInsight. Hidradenitis Suppurativa Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 24 Companies and 26 Therapies |. DelveInsightThe hidradenitis suppurativa market is poised for strong growth driven by increasing disease awareness earlier diagnosis and expanding treatment access. Advances in biologic and targeted therapies particularly the emergen

Thu Oct 23, 2025

$160.12 | -0.17%

Activity

Analysts Estimate Insmed (INSM) to Report a Decline in Earnings: What to Look Out for. Insmed (INSM) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Thu Oct 23, 2025

$160.12 | -0.17%

Earnings

This Is What Whales Are Betting On Insmed. Deep-pocketed investors have adopted a bearish approach towards Insmed (NASDAQ:INSM) and it'.s something market players shouldn'.t ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown but such a substantial move in INSM usually suggests something big is about to happen.We gleaned this information from our observations today when Benzinga'.s options sc

Wed Oct 15, 2025

$163.54 | +1.34%

Activity

Momentum

UBS Maintains Insmed (INSM) Buy Recommendation. Fintel reports that on October 14 2025 UBS maintained coverage of Insmed (NasdaqGS:INSM) with a Buy recommendation. Analyst Price Forecast Suggests 2.79% Downside

Wed Oct 15, 2025

$163.54 | +1.34%

Momentum

Rating

FAQ About INSM Stock Insights

What is INSM current stock price?

What are INSM stock strengths?

What risks are associated with INSM stock?

When is INSM next earnings report?

What is INSM market cap and volume?

What is INSM's current Stock IQ?

Should I buy INSM stock right now?

Is INSM a Strong Buy right now?

What does a 'Strong Buy' rating mean for INSM?

What does a 'Strong Sell' rating mean for INSM?

What factors influence INSM's Stock IQ?

Explore our INSM Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored INSM Stock Strategies
Effective Risk Management

FIND US ON

Receive our INSM Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

INSM

Insmed

Current Price

$194.22

+$27.27 | +16.33%

52W High

$ 194.7

MKT CAP

$ 41.05B

52W Low

$ 60.4

VOL

$ 6.73M

P/E Ratio

N/A

AVG VOL

$ 2.04M

RSI

82.29

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

INSM Rewards

Upgraded on attractively valued

INSM Rewards

Earnings are forecast to grow

INSM Rewards

Investors confidence is positive

Linked to INSM

Symbol

IQ

Close

Change

SNY

4.16

50.94

+0.51%

XOMA

4.00

33.22

-0.37%

REGN

4.17

654.04

+0.17%

MRK

4.08

86.28

-0.35%

MLTX

2.05

9.81

+2.08%

INSM Stock IQ

Login to unlock Insmed (INSM) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$152.8 (+27.11%)

$111.26 (+74.56%)

$70.65 (+174.90%)

$70.14 (+176.90%)

1year

6month

3month

1month

INSM Analysts Opinion

INSM Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

INSM Analysts Opinion

INSM Analysts opinion is negative but has improved from the past 3 months

INSM Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

69%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

40%

100%

INSM Street Opinion

INSM Street view is bullish and have negative views on the near-term outlook

INSM Risk Level

INSM has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

LOW

HIGH

INSM Performance Sentiment

Sentiments overview associated with INSM events and the stock performance.

69%

25%

Positive

Negative

11 out of 16
events present

4 out of 16
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$159.88

Resistance
Price

$137.03

Current Price Range

$167.91

Show methods +

INSM Earnings

The TTM data reflects the most recent 12-month period, providing overview of INSM financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

398

364

305

+14.23%

Cost of Revenue

97

86

66

+21.23%

Gross Profit

301

278

240

+11.99%

Operating Exp

1,229

1,065

921

+15.52%

Operating Inc

-928

-787

-681

-

Net Interest Inc

-85

-82

-

Interest Exp

79

80

76

+1.95%

Interest Inc

1

2

-29.29%

Other Inc Exp

-17

-39

16

-

EPS Growth

-5.67

-5.57

-5.34

-

INSM Financial Health

The company financial health has shown minor improvement, but significant issues remain

Financial Score

3.17

Next Earnings Date: Oct 30, 2025

INSM Latest Analysis

BullPower 02:44 PM

delivered an impressive 16.33% surge today, capturing traders attention with trading volume reaching 329% of its 30-day average at 6.7 million shares. This explosive move in Insmed came after the biotech company reported...

Discover INSM Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of INSM. We're here to help you make informed investment decisions today.

FIND US ON

Receive our INSM Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

INSM Stock trends

INSM Stock performance

INSM Stock analysis

INSM investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing INSM

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing INSM

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

INSM Stock Analysis & IQ Rating | Insmed

INSM Stock IQ

INSM Target Price

INSM Risk Level

INSM Analysts Opinion

INSM Street Consensus

INSM Performance Sentiment

Technical Price Levels

INSM Financial Health

Explore our INSM Stock insights

Receive our INSM Daily Alerts

INSM Stock IQ

INSM Street Consensus

INSM Risk Level

Technical Price Levels

Discover INSM Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of INSM. We're here to help you make informed investment decisions today.

Receive our INSM Daily Alerts

INSM Runner Alarm